KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other Non-Current Liabilities (2018 - 2025)

Twist Bioscience (TWST) has disclosed Other Non-Current Liabilities for 5 consecutive years, with $7.6 million as the latest value for Q4 2022.

  • On a quarterly basis, Other Non-Current Liabilities fell 61.58% to $7.6 million in Q4 2022 year-over-year; TTM through Dec 2022 was $7.6 million, a 61.58% decrease, with the full-year FY2022 number at $60000.0, down 98.82% from a year prior.
  • Other Non-Current Liabilities was $7.6 million for Q4 2022 at Twist Bioscience, up from $60000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $19.7 million in Q4 2021 to a low of $60000.0 in Q3 2022.
  • A 5-year average of $3.1 million and a median of $338500.0 in 2018 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: surged 9266.67% in 2021, then plummeted 98.82% in 2022.
  • Twist Bioscience's Other Non-Current Liabilities stood at $333000.0 in 2018, then tumbled by 56.76% to $144000.0 in 2019, then soared by 45.83% to $210000.0 in 2020, then soared by 9266.67% to $19.7 million in 2021, then tumbled by 61.58% to $7.6 million in 2022.
  • Per Business Quant, the three most recent readings for TWST's Other Non-Current Liabilities are $7.6 million (Q4 2022), $60000.0 (Q3 2022), and $2.1 million (Q2 2022).